Market Place
Sourcing Support
ITM Reveals Higher Response Rates Of (ITM-11) Vs. Everolimus
25 Oct 2025 //
GLOBENEWSWIRE
Results from Amyrt’s Phase 3 Trial of Mycapssa Published in The Lancet
04 Jan 2022 //
TRIALSITENEWS
A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casino
16 Jul 2018 //
ENDPTS
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.